Skip to main content

Sanofi 6-K, filed Oct 30, 2026

Sanofi (SNY)

6-K 2026-10-30 For: 2026-09-30
View Original
Added on October 30, 2026

About this 6-K

Sanofi filed this 6-K on October 30, 2026.

Sanofi reported Q3 2026 net sales of €14,444 million, up 14.3% at CER, and business EPS of €3.55, up 19.6% at CER. It raised 2026 guidance: sales growth is now expected at a low-teens percentage at CER. AI summary